Replimune Group Inc (NASDAQ: REPL) on Friday, plunged -8.44% from the previous trading day, before settling in for the closing price of $9.72. Within the past 52 weeks, REPL’s price has moved between $2.68 and $14.80.
Annual sales at Healthcare sector company slipped by -14.85% over the past five years. The company achieved an average annual earnings per share of -4.40%. With a float of $71.45 million, this company’s outstanding shares have now reached $78.40 million.
Replimune Group Inc (REPL) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Replimune Group Inc is 8.91%, while institutional ownership is 100.39%. The most recent insider transaction that took place on Dec 09 ’25, was worth 32,958. In this transaction Director of this company sold 3,169 shares at a rate of $10.40, taking the stock ownership to the 0 shares. Before that another transaction happened on Dec 09 ’25, when Company’s Director proposed sale 3,164 for $10.38, making the entire transaction worth $32,842.
Replimune Group Inc (REPL) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.79 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.72) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.84 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -4.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.11% during the next five years compared to -14.85% drop over the previous five years of trading.
Replimune Group Inc (NASDAQ: REPL) Trading Performance Indicators
Replimune Group Inc (REPL) is currently performing well based on its current performance indicators. A quick ratio of 6.31 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.61, a number that is poised to hit -0.76 in the next quarter and is forecasted to reach -2.12 in one year’s time.
Technical Analysis of Replimune Group Inc (REPL)
As of the previous 9 days, the stock’s Stochastic %D was 16.24%.
During the past 100 days, Replimune Group Inc’s (REPL) raw stochastic average was set at 71.01%, which indicates a significant increase from 5.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.43 in the past 14 days, which was lower than the 0.49 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.53, while its 200-day Moving Average is $8.00. Nevertheless, the first resistance level for the watch stands at $9.51 in the near term. At $10.12, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.46. If the price goes on to break the first support level at $8.55, it is likely to go to the next support level at $8.21. Assuming the price breaks the second support level, the third support level stands at $7.60.
Replimune Group Inc (NASDAQ: REPL) Key Stats
Market capitalization of the company is 698.15 million based on 78,443K outstanding shares. Right now, sales total 0 K and income totals -247,300 K. The company made 0 K in profit during its latest quarter, and -83,100 K in sales during its previous quarter.
